Jan 6, 2026 06:47AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Dec 15, 2025 08:33AM OKYO Pharma chairman acquires 24,551 shares on NASDAQ

Dec 7, 2025 11:48PM B.Riley Starts OKYO Pharma Ltd. (OKYO) at Buy

Dec 3, 2025 07:01AM OKYO Pharma chairman acquires additional shares on NASDAQ

Nov 21, 2025 08:30AM OKYO Pharma chairman increases stake with 82,018 share purchase

Oct 16, 2025 08:30AM OKYO Pharma chairman acquires 210,000 shares

Sep 23, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Sep 22, 2025 08:35AM OKYO Pharma plans 100-patient trial for neuropathic corneal pain drug

Jul 17, 2025 09:00AM OKYO Pharma receives $1.9 million in non-dilutive funding for drug development

Jul 17, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Jun 11, 2025 10:05AM Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited

Apr 30, 2025 07:04AM OKYO Pharma (OKYO) Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain

Mar 31, 2025 08:04AM OKYO Pharma (OKYO) Announces Positive Data in Long-Term Stability of Urcosimod

Mar 10, 2025 08:32AM OKYO Pharma (OKYO) Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain

Feb 18, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Feb 12, 2025 07:01AM OKYO Pharma (OKYO) Announces OK-101 Officially Assigned USAN : Urcosimod

Feb 11, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Jan 31, 2025 07:00AM OKYO Pharma (OKYO) Announces Chairman and CEO Acquire Shares

Jan 30, 2025 09:45AM Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited

Jan 29, 2025 08:03AM OKYO Pharma (OKYO) to Complete Enrollment of Neuropathic Corneal Pain Trial by End of Second Quarter

Jan 22, 2025 07:01AM OKYO Pharma (OKYO) Receives $1.4 Million in Non-Dilutive Funding

Nov 15, 2024 09:00AM MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 24, 2024 07:44AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Oct 23, 2024 07:12AM OKYO Pharma (OKYO) Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain

Oct 17, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Oct 16, 2024 07:03AM OKYO Pharma (OKYO) Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain

Sep 10, 2024 07:03AM OKYO Pharma (OKYO) Announces Chairman Acquires Shares

Sep 5, 2024 07:00AM OKYO Pharma (OKYO) Announces Chairman Acquired 80K Shares

Aug 28, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Aug 27, 2024 07:01AM OKYO Pharma (OKYO) Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease

Aug 23, 2024 09:00AM OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 21, 2024 07:01AM OKYO Pharma (OKYO) Announces 35K Share Insider Buy by Chairman

Aug 6, 2024 07:01AM OKYO Pharma (OKYO) Granted European Patent for OK-101

Jul 12, 2024 08:18AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Jul 11, 2024 10:32AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)

Jul 11, 2024 07:01AM OKYO Pharma (OKYO) to Initiate Neuropathic Corneal Pain Trial for OK-101

Jul 10, 2024 07:00AM OKYO Pharma (OKYO) Reports Promising Categorical Data from OK-101 Trial